Response to the letter: Hyperprogression in advanced melanoma is not restricted to immunotherapy

被引：0
|
作者：
Fournier, Marie [1 ]
Mortier, Laurent [2 ]
Dereure, Olivier [3 ]
Dalac, Sophie [4 ]
Oriano, Bastien [1 ]
Dalle, Stephane [5 ]
Lebbe, Celeste [6 ]
机构：
[1] Univ Paris Cite, AP HP Hop St Louis, Dermatol Dept, Paris, France
[2] CHRU Lille, Dermatol Dept, Lille, France
[3] Univ Montpellier, Dept Dermatol, Montpellier, France
[4] CHU Dijon, Dermatol Dept, Dijon, France
[5] CHU Lyon Sud, Dept Anesthesiol, Lyon, France
[6] Univ Paris Cite, Nord Univ Paris Cite, Dermato Oncol AP HP Hop Saint Louis, Canc Inst APHP,INSERM,U976, F-75010 Paris, France
来源：
EUROPEAN JOURNAL OF CANCER | 2024年 / 200卷
关键词：
D O I：
10.1016/j.ejca.2024.113562
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Hyperprogression in advanced melanoma is not restricted to immunotherapy
    Fournier, Marie
    Mortier, Laurent
    Dereure, Olivier
    Dalac, Sophie
    Oriano, Bastien
    Dalle, Stephane
    Lebbe, Celeste
    [J]. EUROPEAN JOURNAL OF CANCER, 2023, 193
  • [2] Hyperprogression in advanced melanoma is not restricted to immunotherapy
    Yang, Fan
    Xu, Nan
    [J]. EUROPEAN JOURNAL OF CANCER, 2024, 199
  • [3] Hyperprogression of advanced Melanoma Disease with Pembrolizumab adjuvant
    Geidel, G.
    Ammann, N.
    Schneider, S. W.
    Gebhardt, C.
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 5 - 6
  • [4] Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
    Frelaut, Maxime
    du Rusquec, Pauline
    de Moura, Alexandre
    Le Tourneau, Christophe
    Borcoman, Edith
    [J]. BIODRUGS, 2020, 34 (04) : 463 - 476
  • [5] Hyperprogression: A novel response pattern under immunotherapy
    Han, Xue-jiao
    Alu, Aqu
    Xiao, Yi-nan
    Wei, Yu-quan
    Wei, Xia-wei
    [J]. CLINICAL AND TRANSLATIONAL MEDICINE, 2020, 10 (05):
  • [6] Pseudoprogression and Hyperprogression as New Forms of Response to Immunotherapy
    Maxime Frelaut
    Pauline du Rusquec
    Alexandre de Moura
    Christophe Le Tourneau
    Edith Borcoman
    [J]. BioDrugs, 2020, 34 : 463 - 476
  • [7] Hyperprogression during immunotherapy
    Isobel Leake
    [J]. Nature Cancer, 2023, 4 : 1640 - 1640
  • [8] Hyperprogression under immunotherapy: a new form of immunotherapy response?-a narrative literature review
    Lin, Miaozhen
    Vanneste, Ben G. L.
    Yu, Qiwen
    Chen, Zebin
    Peng, Jiayu
    Cai, Xiuyu
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2021, 10 (07) : 3276 - 3291
  • [9] Hyperprogression during immunotherapy
    Leake, Isobel
    [J]. NATURE CANCER, 2023, 4 (12) : 1640 - 1640
  • [10] Hyperprogression after immunotherapy
    Abbas, Waseem
    Rao, Ranga Raju
    Popli, Swati
    [J]. SOUTH ASIAN JOURNAL OF CANCER, 2019, 8 (04) : 244 - 246
12345